SAB Biotherapeutics Inc.

NASDAQ: SABS
Share price (12/20/24): $4.65
Market cap (12/20/24): $42.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

Late quarterly filing notification for Q1 2024

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration – amended

Shelf registration

Ownership Filter

Ellias Helen K.

Link David Charles

News Filter

BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting

BIO Appoints Lucy to as Chief Financial Officer

Shareholder Vote Results

Announces Departure of Chief Financial Officer

FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC